Protokoly_diagnostiki_i_lechenia_zabolevany

G " " $# " :

) % " " " " V 300 ;

+ ;

B " # ;

" ;

' % & , " ,

" ( " & " 3

" & :

1.2% V ,

2.*@ V 1% 1

3.*J 250 , 500

4.*6 , 250

5." &

6.*š + + +' 25

7.*7 250

8.*@ V 5 / 2

" & & :

,- ! :

! & " .

/ , & :

1.@ & . >% " . , 3, . 229-231

2.http://www.ebm-guidelines.com/ , Benign prostatic hyperplasia;

3.http://www.uriligyhealth.org/ , Surgical Management of BPH, 2001;

4.Prodigy Guidance – Prostate – benign gyperplasia, 2002.

* – , # (% % ) .

) : – $ " (< & ). 6 – ;" # % ( " ). " & &. & & "" % . + [ . (membrana) tympani+ ; : , ]— ,$# & "$# 3. < – , # $# 3 ; "" ; " " , 3

% $# & :

! ). 7 ;? 6>@B/B+?, 6., 2000

2.< & 3 . www.neuro.net.ru/bibliot/bme/des/des796html

3.6 3 . www.rubricon/mme_ann/

4.@ & . " " " ,& . 2 . > ;? , 2002.

5.Cholesteatoma and Otosclerosis: Two slowly progressive causes of hearing loss treatable through corrective surgery. Clinical Medicine & Research, 2003, V.1, N.2, .151. James J. Holt.

* – , # (% % ) .

. ! .

: 02-018

"$ &: " :

& !: , % % .

' & & ( ): 8

(: H25 ! " H26 @ Q12.2

) : – " " # , # %$ & .

$ : : % , .

3 " : ; % ( , ," ); " ( , $# ); " ; ( " , " , " ); , $# " # ( & , , , , , ) J! ( !, & , , & , , , ); " (

" ( & K ), @ , 13 15 ; ; & & .

5 :

# , # " , & RW, , & , ?J;, ?!;, $, 7 ( ), $" ,

% & [ , .

" & :

1.& " :

2.+ %

3. < #&$ #

4.B ' @

5." B J

6.H)B

7.?

8.@

9.7 "

10./ # #

11.HbsAg, Anti-HCV.

" & & :

1.7

2.7

3.B " " &

4./ &

5."

+ : @ % " ". $# &$# " " .

' @, $, [ . : % & # ( & ).

: 3 3 ,3 .

$ , – & B J – Cristal, Acrysof, Natural, Restor, 3 .

( 0,25% , 0,02% , &

1 & 6-9 . 0,1% 1 4 & 6-9 , $ 40%.

' @ - : - 1%, 5% 2 2& 6 . < 1 2 & – 6 .

" & :

1.*G

2.*+

3.*! & 30%

4.*@ ( ) 0,1% 10

5.*@ 25 , 100 , 150 ,

6.*? V ( & ) 0,1% 1

7.* V 30 /

8.*; 0,5%, 1% 5

" & & :,- ! :

/ , & :

1.American Academy of Ophthalmology. Guideline. Cataract in the Adult Eye. 2001

2.ICO International Clinical Guidelines. Cataract (Initial evaluation) 2005.

3.EBM Guidelines. Cataract. 2004.

4.Alberta Medical Association. Clinical Practice Guideline. Surgical and Non-Surgical Management of Cataract in the Otherwise Healthy Adult Eye. 2005.

5.American Academy of Ophthalmology. Cataract (Initial and follow-up evaluation). 2003.

6.National Guideline Clearinghouse. Clinical Practice Guideline for the Management of Cataract Among Adults. 2005.

* – , # (% % ) .

, , , , ,

$ $ " , & % % & 3 .

" & :

1.#

2.# "

4."

6."

7.B_?

8.#

10."

11.$

12.?J;

13.?!;

14.;

15. -

16.? " + "

17.? " )

18."

20." %

21.L & &

22.H)B $

23.7

24."

26.7

27.&$ "

29.HbsAg, Anti-HCV.

" & & :

1.&

2.&

+ :

1. " " . ' " "$ : 1) & ( " )$# " 2) " % & 3 % , ". @ " % &, & " % $# # : , , , , , 3 .

2.– .

3.@ .

4.? & . + " & ; ( 40-80 / 2 . &,10 / 2 . " 7-10 ),( 20-10 " 7-10 ,

50-100 " 7-10 ). +" 50-100 3 . " 10 , 500 3 . & " 12 , 1-2 3 . & " 10-14 .

: + " " , $#

" & :

1. *; V 1% 1

2.*@ V 1% 1

3.*- 1%

4.*@ 200 , 400

5.*$ 5%, 10% 400 , 500 ; 40% 5 , 10

6.*+ 0,9% V

7. * , " ( % % )

8.* V 40 / , 80 /2

9.*/ V 250 , 500 , 1 000

10.*? 200 /100

11.*? V 5%, 10% 2 , 5

12.+ 200

13.*+ 500 000 >@

14.*_ 50 , 150 ; / 100

15.J ,

16.*< 1%, 2% 10 , 20

17.* & 3% 25 , 40

18._ 1:5000

19.*7 70% ( )

20.*? V 0,1 1 ( & )

" & & :

1.* , " (3 )

2.* 2500 6> V

3.*B V 100 6>/

1.+ " +.?., + " ?.+., < ?.?., ) " &

" " ;

2.R de Bruyn, I Gordon, Imaging in cystic renal disease. Arch Dis Child 2000;83: 401-407;

3.http://www.urologyhealth.org, Renal Dysplasia and Cystic Disease;

. ) & %: 02-018

"$ &: " :

& !: , , , & .

' & & ( ): 9

(: H50 @

) : - & # " .

$ :

- % , "

-" , "

-# , # &

-& , &$#

-, " " ,

-" ,

* : & ,

" :

" : ,, " .

5 : #(6 ), # " , , & , ?J;, ?!;, 7 ( ), $" , , J-" , .

: % , " ,.

" & :

1.'

4.V V

6.!

7.<

8.&

9.HbsAg, Anti-HCV.

" & & :

1.H)B

2.7

3.B " " &

4.7

+ : $ " & 10 , & ( " &$). & %& & .

( – 5-30 ").

# .

: @ .